Smith & Nephew to present today at JP Morgan

RNS Number : 3008M

Smith & Nephew Plc

07 January 2019

 

Smith & Nephew to present today at J.P. Morgan Healthcare Conference

7 January 2019

Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, will participate in the 37th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, San Francisco, California, USA.

Namal Nawana, Chief Executive Officer, will present today at 8.30am Pacific Time (4.30pm GMT) on Monday 7 January 2019, followed by a Question & Answer session at 9.00am.

Live webcasts of the presentation and Q&A will be accessible via the events section on the Smith & Nephew investor relations website.  Transcripts of both will be available shortly thereafter.

There will be no update on trading during the presentation or Q&A. Smith & Nephew confirms that it expects to meet its 2018 full year guidance, as disclosed in its Third Quarter Trading Report on 1 November 2018, and will publish its fourth quarter and full year results for 2018 on 7 February 2019.

Enquiries

Investors
Andrew Swift Smith & Nephew	[phone]
Media
Charles Reynolds Smith & Nephew	[phone]
Ben Atwell / Andrew Ward FTI Consulting	[phone]

About Smith & Nephew

Smith & Nephew is a portfolio medical technology business with leadership positions in Orthopaedics, Wound, Sports Medicine and ENT. Smith & Nephew has more than 15,000 employees and a presence in more than 100 countries. Annual sales in 2017 were almost $4.8 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN). For more information about Smith & Nephew, please visit our corporate website www.smith-nephew.com and follow us on Twitter, LinkedIn or Facebook.

Forward-looking Statements

This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.

 

END

 

 

MSCCKPDNFBKKCDK